StarCaps shipping stopped
This article was originally published in The Tan Sheet
Executive Summary
Los Angeles-based marketer Nikki Haskell suspends shipping the weight-loss supplement after a National Football League player alleged Oct. 28 that the product was tainted with bumetanide, a diuretic the NFL banned because it may mask steroid use. In an e-mail, StarCaps said it is aware of the lawsuit filed in New Jersey federal court by New Orleans Saints player Jamar Nesbit and is taking steps to ensure customers receive a safe and effective product. Nesbitt served a four-game suspension after he tested positive for the banned substance. Nesbitt did not appeal the suspension, but another Saints player who also tested positive for bumetanide after using StarCaps is appealing his suspensions. According to ads, StarCaps contains papaya, garlic, valerian, corn spices, papain, magnesium carbonate and magnesium oxide. Nesbitt's lawsuit comes as Congress presses for tighter regulation of supplements, partly due to athletes' complaints about products tainted with steroid ingredients. Industry says supplements are a scapegoat for intentional steroid use
You may also be interested in...
StarCaps recall expanded
Balanced Health Products expands its voluntary recall of StarCaps Diet Systemto include additional lots - numbers 12/2009-82866 and 12/2010-8301 - because the capsules in the 30-count bottles contain the undeclared ingredient bumetanide, a diuretic that can cause serious fluid and electrolyte loss. The firm says in a Dec. 8 release it believes an additional lot of raw material was contaminated with bumetanide in Lima, Peru. The company suspended StarCaps shipments after National Football League players alleged the product contained bumetanide, which can mask steroid use (1"The Tan Sheet" Nov. 3, 2008, In Brief)
Diuretic found in StarCaps
Balanced Health Products voluntarily recalls one lot of the weight-loss supplement, which contained the undeclared diuretic bumetanide, FDA says Nov. 24. Bumetanide can cause serious loss of fluids and electrolytes and elevated uric acid concentrations. The New York City-based firm's president, Nikki Haskell, suspended shipment of StarCaps after National Football League players alleged the product was tainted after they were suspended for testing positive for bumetanide, which may mask steroid use (1"The Tan Sheet" Nov. 3, 2008, In Brief)
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.